May 2, 2013 – As concerns have been raised over the past few months about Januvia’s ability to cause pancreatitis and pancreatic cancer, drugmaker Merck & Co. suffered a significant hit to its profits over the last quarter. This week, the pharmaceutical giant announced that its first quarter earnings for this year were nearly 20% less than expected, and 4% less than the first quarter of 2012.
Free Januvia Lawsuit Evaluation: If you or a loved one has been diagnosed with pancreatic cancer after taking Januvia, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
While Merck claims that the drop in profits was due to inventory reductions, industry insiders have speculated that demand for Januvia has dropped amid mounting research and numerous case studies which suggest a link between the drug and pancreatic cancer. The correlation is so convincing that the FDA and various foreign regulatory agencies have launched investigations to study the pancreatic toxicity of Januvia and other incretin mimetic type 2 diabetes drugs.
Overall, Merck suffered a 9% drop in total first quarter sales, which brought in $10.7 billion in revenue, about $1 billion less than analysts predicted. Janumet, another incretin mimetic diabetes drug manufactured by Merck, also posted weak sales, growing by only 4% and bringing in about $409 million. That is substantially less than its growth in the first quarter of last year, which may also be linked to concerns over the drug’s potential to cause pancreatic cancer.
Recent concerns about the effect of incretin mimetic diabetes drugs on the pancreas have resulted in a growing number of product liability lawsuits against the manufacturers of these products. The complaints allege that the public and medical communities were not adequately warned about the drugs’ potential serious side effects, and that the companies withheld information and failed to inform users about the importance of monitoring the pancreas during treatment.
Do I Have a Januvia Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Januvia lawsuits. We are handling individual litigation nationwide and currently accepting new pancreatic cancer cases in all 50 states.
Free Januvia Lawsuit Evaluation: If you or a loved one has been diagnosed with pancreatic cancer after taking Januvia, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.